Cross-protective antibodies against common endemic respiratory viruses
Abstract Respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and human parainfluenza virus types one (HPIV1) and three (HPIV3) can cause severe disease and death in immunocompromised patients, the elderly, and those with underlying lung disease. A protective monoclonal antibody exists f...
Main Authors: | Madelyn Cabán, Justas V. Rodarte, Madeleine Bibby, Matthew D. Gray, Justin J. Taylor, Marie Pancera, Jim Boonyaratanakornkit |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-36459-3 |
Similar Items
-
Protective antibodies against human parainfluenza virus type 3 infection
by: Jim Boonyaratanakornkit, et al.
Published: (2021-01-01) -
Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43
by: Jim Boonyaratanakornkit, et al.
Published: (2021-10-01) -
Techniques to Study Antigen-Specific B Cell Responses
by: Jim Boonyaratanakornkit, et al.
Published: (2019-07-01) -
Protective antibodies to plasmodium falciparum and immunity to malaria in an endemic area of Brazil
by: Carlos Eduardo Tosta, et al.
Published: (1986-01-01) -
Respiratory Syncytial Virus Infection in Homeless Populations, Washington, USA
by: Jim Boonyaratanakornkit, et al.
Published: (2019-07-01)